{"retracted":false,"update":{"timestamp":1455667200000,"doi":"10.1186/s12885-016-2163-y","type":"correction"},"doi":"10.1186/s12885-015-1142-z","journal":"BMC Cancer","publisher":"Springer Nature","title":"Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer"}
